Stock Events

Stock Events

Patrys Limited 

$0.06
0
+$0+0% Friday 13:30

Statistics

Day High
0.06
Day Low
0.06
52W High
0.06
52W Low
0.04
Volume
20,000
Avg. Volume
-
Mkt Cap
20.44M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-367.75%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
1.06MRevenue
-3.9MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PABAF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Macrogenics
MGNX
Mkt Cap193.86M
MacroGenics develops monoclonal antibody-based therapeutics for the treatment of cancer, competing in the same biotechnological sector as Patrys.
Allogene Therapeutics
ALLO
Mkt Cap794.59M
Allogene Therapeutics focuses on allogeneic CAR T therapies for cancers, competing in the next-generation cancer therapy space.
Sangamo Therapeutics
SGMO
Mkt Cap78.75M
Sangamo Therapeutics works on genomic therapies for cancer among other diseases, competing in the genetic and cellular therapy arena.
Novartis
NVS
Mkt Cap280.79B
Novartis is a large pharmaceutical company with a significant portfolio in innovative cancer therapies, including CAR T-cell products.
Gilead Sciences
GILD
Mkt Cap161.85B
Gilead Sciences, through its acquisition of Kite Pharma, competes in the cellular therapy space for cancer, similar to Patrys' therapeutic focus.

About

Patrys Limited, together with its subsidiaries, develops antibody technologies for the treatment of cancer and NETosis-driven inflammatory diseases. It develops PAT-DX1, a small antibody fragment derived from a humanized version of the binding domain from the original mouse deoxymab antibody 3E10; and PAT-DX3 for treating primary and secondary brain cancers, and metastases that are associated with NETosis, or in combination with DNA damaging agents, such as radiation and other chemotherapy drugs. The company was incorporated in 2006 and is based in Nedlands, Australia.
Show more...
CEO
ISIN
AU000000PAB9

Listings

OTC Link
US
PABAF
AU
AU
PAB.AU

0 Comments

Share your thoughts

FAQ

What is Patrys Limited stock price today?▼
The current price of PABAF is $0.06 USD — it has increased by +0% in the past 24 hours. Watch Patrys Limited stock price performance more closely on the chart.
What is Patrys Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Patrys Limited stocks are traded under the ticker PABAF.
What is Patrys Limited market cap?▼
Today Patrys Limited has the market capitalization of 20.44M
What is Patrys Limited revenue for the last year?▼
Patrys Limited revenue for the last year amounts to 1.06M USD.
What is Patrys Limited net income for the last year?▼
PABAF net income for the last year is -3.9M USD.
In which sector is Patrys Limited located?▼
Patrys Limited operates in the Other sector.
When did Patrys Limited complete a stock split?▼
The last stock split for Patrys Limited was on October 13, 2025 with a ratio of 1:15.